Jushi Holdings (JUSHF) Retained Earnings (2021 - 2026)
Jushi Holdings (JUSHF) reported Retained Earnings of -$647.1 million for Q1 2026, down 12.41% year-over-year from -$738.7 million in Q1 2025, and down 3.16% quarter-over-quarter from -$627.2 million in Q4 2025.
Jushi Holdings (JUSHF) Retained Earnings (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Retained Earnings data on file, last reported at -$647.1 million in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$647.1 million, down 12.41% year-over-year; the trailing twelve-month figure through Mar 2026 was -$647.1 million (down 12.41% YoY), and the FY2025 annual result was -$627.2 million, down 12.28% from the prior year.
- Retained Earnings retreated to -$647.1 million in Q1 2026 per JUSHF's latest filing, from -$627.2 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$250.1 million in Q2 2022 and troughed at -$647.1 million in Q1 2026.
- A 5-year average of -$508.9 million and a median of -$529.2 million in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2025: Retained Earnings tumbled 88.41% in 2023, then slipped 8.98% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$444.7 million in 2022, then decreased by 14.64% to -$509.8 million in 2023, then retreated by 9.57% to -$558.6 million in 2024, then decreased by 12.28% to -$627.2 million in 2025, then declined by 3.16% to -$647.1 million in 2026.
- Business Quant data shows JUSHF's Retained Earnings at -$647.1 million in Q1 2026, -$627.2 million in Q4 2025, and -$611.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -2.51 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -772.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -10.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 683,383.23 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 589.60 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -2.13 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.91 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -4.41 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -1.87 Mn |
| 10 | Jushi Holdings | - | - | 29.88 Mn | -647.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -647.06 Mn |
| Dec 31, 2025 | -627.21 Mn |
| Sep 30, 2025 | -611.66 Mn |
| Jun 30, 2025 | -587.97 Mn |
| Mar 31, 2025 | -575.64 Mn |
| Dec 31, 2024 | -558.62 Mn |
| Sep 30, 2024 | -546.15 Mn |
| Jun 30, 2024 | -530.14 Mn |
| Mar 31, 2024 | -528.20 Mn |
| Dec 31, 2023 | -509.84 Mn |
| Sep 30, 2023 | -491.84 Mn |
| Jun 30, 2023 | -471.22 Mn |
| Mar 31, 2023 | -457.18 Mn |
| Dec 31, 2022 | -444.74 Mn |
| Sep 30, 2022 | -304.81 Mn |
| Jun 30, 2022 | -250.11 Mn |
| Dec 31, 2021 | -242.42 Mn |